BPG is committed to discovery and dissemination of knowledge
Articles in Press
6/27/2022 12:04:36 AM | Browse: 51 | Download: 75
Publication Name World Journal of Clinical Oncology
Manuscript ID 75447
Country Italy
Category Oncology
Manuscript Type Case Control Study
Article Title Edmonton Symptom Assessment Scale may reduce medical visits in patients undergoing chemotherapy for breast cancer
Manuscript Source Invited Manuscript
All Author List Valeria Sanna, Palma Fedele, Giulia Deiana, Maria G Alicicco, Chiara Ninniri, Anna N Santoro, Antonio Pazzola and Alessandro Fancellu
Funding Agency and Grant Number
Corresponding Author Alessandro Fancellu, FACS, MD, PhD, Associate Professor, Department of Medical, Surgical and Experimental Sciences, Unit of General Surgery 2-Clinica Chirurgica, University of Sassari, V.le San Pietro 43, Sassari 07100, Italy. afancel@uniss.it
Key Words Edmonton system assessment scale; Adjuvant chemotherapy; Breast cancer; Medical visits; Patient-reported outcomes
Core Tip Adjuvant chemotherapy is recommended in high-risk breast cancer. We hypothesized that the Edmonton Symptom Assessment Scale (ESAS) can be used to safely reduce the number of medical visits in women with breast cancer undergoing adjuvant chemotherapy. The main result of this case-matched analysis is that ESAS screening may safely reduce the frequency of medical visits in the setting of AC in patients with breast cancer. This finding may have some advantageous implications in oncological practice, especially in the current scenario, where an increase in COVID-19 cases throughout the world has imposed measures for minimising the risk of infection among patients and health care providers.
Citation Sanna V, Fedele P, Deiana G, Alicicco MG, Ninniri C, Santoro AN, Pazzola A, Fancellu A. Edmonton Symptom Assessment Scale may reduce medical visits in patients undergoing chemotherapy for breast cancer. World J Clin Oncol 2022; 13(7): 577-586
Received
2022-01-29 07:35
Peer-Review Started
2022-01-29 07:37
To Make the First Decision
Return for Revision
2022-05-12 08:41
Revised
2022-06-05 21:21
Second Decision
2022-06-20 03:04
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief
2022-06-27 00:04
Articles in Press
2022-06-27 00:04
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2022-07-01 07:29
ISSN 2218-4333 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright ©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved.
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com